[
    {
        "releaseTime": "Jan-28-23 05:30AM",
        "title": "2 of the Best Dividend Stocks to Own in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/1b758875-d8a2-35ef-a21a-65fa9b6ab045/2-of-the-best-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-26-23 10:20AM",
        "title": "12 Cheap Blue Chip Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-blue-chip-stocks-152041107.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 05:20PM",
        "title": "3 Gene Editing Stocks to Buy Now OR Youll Be Kicking Yourself Later",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-gene-editing-stocks-buy-222018942.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 10:37AM",
        "title": "12 Cheap Biotech Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-biotech-stocks-buy-153727204.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 09:00AM",
        "title": "Allergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/allergan-aesthetics-takes-360-approach-140000083.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 07:05AM",
        "title": "3 Reasons to Buy AbbVie and 2 Reasons Not to Buy",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2d66f5a9-df8d-30f8-8f7c-1e88b71f473e/3-reasons-to-buy-abbvie-and-2.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-25-23 06:00AM",
        "title": "Want Safety and Growth in 2023? Try These Dividend Stocks.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bd71ffda-96a5-3909-bbc3-c8929ff40ae6/want-safety-and-growth-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-23-23 05:45PM",
        "title": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-224510908.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-23-23 09:00AM",
        "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002846.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-22-23 07:05PM",
        "title": "2 Top Passive-Income Stocks to Own in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/633d2db6-6645-305b-9201-f0b8ed4dc254/2-top-passive-income-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-22-23 05:30AM",
        "title": "AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/20bcc229-7bc5-39c3-88db-cb21161f89c3/abbvie-is-set-to-lose-on-its.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-19-23 05:30AM",
        "title": "3 Unstoppable Stocks to Keep Buying in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/04cd187e-026b-30af-ac6d-168fadd32c0d/3-unstoppable-stocks-to-keep.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 05:32PM",
        "title": "One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/ad407f57-05f9-382d-a10e-93a424c58712/one-of-the-greatest-cancer.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 03:44PM",
        "title": "7 Biotech Stocks That Will Make You Rich in 10 Years",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-biotech-stocks-rich-10-204449431.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 09:53AM",
        "title": "2 Cheap Growth Stocks That Can Set You Up for Life",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c0831a57-6e87-3983-a821-a27b288843e5/2-cheap-growth-stocks-that.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 09:20AM",
        "title": "14 Best Dividend Stocks To Buy and Hold",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/14-best-dividend-stocks-buy-142029008.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-18-23 08:00AM",
        "title": "JUVÉDERM® VOLUX XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/juv-derm-volux-xc-improvement-130000644.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 05:45PM",
        "title": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-dips-more-broader-224510389.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 10:07AM",
        "title": "Could This FDA Approval Boost AbbVie's Stock?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/526955d0-9e60-3696-83aa-e7fb492d93fc/could-this-fda-approval-boost.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 10:00AM",
        "title": "12 Best DRIP Stocks To Own",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-best-drip-stocks-own-150032179.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 08:00AM",
        "title": "SkinMedica® Launches Even & Correct",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/skinmedica-launches-even-correct-130000589.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 07:45AM",
        "title": "With Competition on the Rise, Is AbbVie's Dividend Safe?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2c95e890-3e4a-328f-80ac-3a174bc284af/with-competition-on-the-rise%2C.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 06:03AM",
        "title": "AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/abbvie-eli-lilly-leave-uks-110320254.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-17-23 05:47AM",
        "title": "Is AbbVie a Good Dividend Stock to Buy on the Dip?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5f8a9da4-6c64-3c6f-be6b-7fc92bfb1df0/is-abbvie-a-good-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 09:00AM",
        "title": "Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/sirona-biochem-announces-termination-supply-140000910.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 08:45AM",
        "title": "5 Dividend Kings I Bought for My Portfolio",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6329730c-c4db-3ab9-af9a-b99e4a95ae35/5-dividend-kings-i-bought-for.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 06:34AM",
        "title": "US drugmakers withdraw from NHS pricing agreement as costs soar",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/71bf4065-58c4-3b36-a6eb-27f462b8bbb4/us-drugmakers-withdraw-from.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-16-23 04:24AM",
        "title": "UPDATE 1-AbbVie, Eli Lilly exit UK drug pricing agreement",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-abbvie-eli-lilly-exit-092402473.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-14-23 01:22PM",
        "title": "12 Cheap Monthly Dividend Stocks To Buy",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-cheap-monthly-dividend-stocks-182235031.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-14-23 10:03AM",
        "title": "A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/607887bb-0f3a-32d9-8879-78f883c49691/a-new-u.s.-law-aims-to-reduce.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-13-23 09:45AM",
        "title": "Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/eec3932c-130c-3c2d-a206-0d2c1bfa047b/want-to-get-richer%3F-3-best.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-12-23 05:00AM",
        "title": "Zacks Market Edge Highlights: EXAS, ZM, TSLA, ABBV, ZOM",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-market-edge-highlights-exas-100010824.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 04:01PM",
        "title": "The Stocks Behind 2022's Popular ETFs",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/stocks-behind-2022s-popular-etfs-210109806.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 07:50AM",
        "title": "3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/552035f1-06fe-324e-bd7a-04a4e5b84ea0/3-supercharged-dividend.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 07:10AM",
        "title": "If You Like Dividends, You Should Love These 3 Stocks",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bba50609-adca-397f-adb2-99c2fc7d6c65/if-you-like-dividends%2C-you.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-11-23 05:30AM",
        "title": "1 Hot Growth Stock to Buy Now, and 1 to Avoid",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/cb2d0740-bb0d-3b5c-a0e2-914e49ca6831/1-hot-growth-stock-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:45PM",
        "title": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-224510089.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 12:28PM",
        "title": "AbbVie (NYSE:ABBV) Is Paying Out A Larger Dividend Than Last Year",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-nyse-abbv-paying-larger-172842758.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:45AM",
        "title": "3 Passive Income Stocks That Are Screaming Buys in January",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0712124f-af1a-30ec-bca0-2d96da6c515a/3-passive-income-stocks-that.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:12AM",
        "title": "Abbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/abbvie-raises-sales-outlook-two-141249692.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:02AM",
        "title": "UPDATE 2-Abbvie raises sales outlook of two immunology drugs to more than $17.5 bln in 2025",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-abbvie-raises-sales-outlook-140239478.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 09:00AM",
        "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002633.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 08:00AM",
        "title": "AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-anima-biotech-announce-collaboration-130000427.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 07:00AM",
        "title": "Fund Soars By Focusing On Income Stocks, Shunning Sector Bets",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/020c3dc4-45d5-310c-800b-a8c34fa51c1e/fund-soars-by-focusing-on.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:52AM",
        "title": "3 Top Dividend Kings to Buy for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/04b6528a-5a1c-3c0f-bffc-2054da0284c4/3-top-dividend-kings-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-10-23 05:31AM",
        "title": "Should Investors Worry About AbbVie's Dividend?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/28f3ee73-2be7-31af-9542-25055d6f7b39/should-investors-worry-about.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-09-23 12:48PM",
        "title": "These 15 Dividend Aristocrat stocks have been the best income builders",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/1b7e0d78-de46-3028-974a-09de73d8bbdb/these-15-dividend-aristocrat.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-09-23 07:01AM",
        "title": "QULIPTA Now Approved by Health Canada for the Preventive Treatment of Episodic Migraine in Adults",
        "publisher": " CNW Group",
        "webUrl": "https://finance.yahoo.com/news/qulipta-now-approved-health-canada-120100178.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-07-23 06:10AM",
        "title": "3 No-Brainer Dividend Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/fa2a59c1-bff5-3d9d-a22c-aa17c6ae4617/3-no-brainer-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 06:44PM",
        "title": "AbbVie cuts earnings forecast due to milestone payments",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/e3607475-27a2-34f5-ac11-47fd61b2e737/abbvie-cuts-earnings-forecast.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 04:05PM",
        "title": "AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/72409e82-d243-3588-9450-242a37a36e0f/abbvie-briefly-breaks-out.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 02:46PM",
        "title": "Immunome enters into a cancer drug collaboration with AbbVie worth up to $2.8B",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/043d8649-e13c-3ce0-b568-6b4d80d8f489/immunome-enters-into-a-cancer.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 01:46PM",
        "title": "CytomX (CTMX) Up 55% on Strategic Partnership With Moderna",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/cytomx-ctmx-55-strategic-partnership-184606299.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 10:35AM",
        "title": "Immunome Stock Jumps On Discovery Pact With AbbVie",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/immunome-stock-jumps-discovery-pact-153501768.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 08:30AM",
        "title": "3 Top U.S. Stocks to Watch in January",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9e75c6d8-de8d-325d-97d8-54b0b1a7a805/3-top-u.s.-stocks-to-watch-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-06-23 08:00AM",
        "title": "AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-immunome-announce-strategic-collaboration-130000933.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 05:11PM",
        "title": "CytomX shares surge more than 50% on Moderna partnership",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/79beb108-b773-3b30-829f-9e305420c05d/cytomx-shares-surge-more-than.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 08:00AM",
        "title": "AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-host-fourth-quarter-2022-130000276.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 07:01AM",
        "title": "AbbVie (NYSE:ABBV) Seems To Use Debt Quite Sensibly",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-nyse-abbv-seems-debt-120103434.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-05-23 05:06AM",
        "title": "Why investors should stop fixating on Apple and Tesla stock in 2023: Morning Brief",
        "publisher": " Yahoo Finance",
        "webUrl": "https://finance.yahoo.com/news/why-investors-should-stop-fixating-on-apple-and-tesla-stock-in-2023-morning-brief-100616180.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-04-23 10:23AM",
        "title": "These 2 Cheap Dividend Stocks Yield More Than 3% -- and They Beat the Market Last Year",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/ff4830ac-81be-3158-9d93-87f6ee6e19e5/these-2-cheap-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-04-23 09:15AM",
        "title": "1 Smart Trick That'll Make You a Better Investor Instantly",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e89a0cb2-1a76-310b-85ab-67a993f02cca/1-smart-trick-that%27ll-make.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-04-23 05:11AM",
        "title": "3 Outstanding Dividend Growth Stocks to Buy for 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/7daf2e03-856b-3134-b309-702b01236428/3-outstanding-dividend-growth.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-03-23 05:45PM",
        "title": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-gains-market-dips-224510706.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-03-23 10:23AM",
        "title": "Beat the Dow Jones With This Unstoppable Dividend Stock",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/3ba3163b-7028-3176-be80-ae25f432d72c/beat-the-dow-jones-with-this.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-03-23 08:00AM",
        "title": "AbbVie to Present at the 41st Annual J.P. Morgan Healthcare Conference",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/abbvie-present-41st-annual-j-130000264.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-03-23 05:55AM",
        "title": "23 Top Dividend Stocks to Buy and Hold in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/62d12144-6251-371a-b093-f52e5d830f39/23-top-dividend-stocks-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Jan-01-23 09:00AM",
        "title": "AbbVie Inc. (NYSE:ABBV) is favoured by institutional owners who hold 70% of the company",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-favoured-140020616.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-31-22 08:15AM",
        "title": "3 Dividend Stocks to Buy Hand Over Fist in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/f05d3bdc-7ecf-368c-a0af-9bc561a0f50d/3-dividend-stocks-to-buy-hand.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-31-22 07:25AM",
        "title": "3 Best Value Stocks to Buy Before 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/edd52522-9dae-3daa-93f1-fb291c9edd19/3-best-value-stocks-to-buy.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-30-22 11:50AM",
        "title": "10 Best Dividend Stocks to Buy According to Morgan Stanleys Quant Screen: In Retrospect",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-best-dividend-stocks-buy-165013702.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-30-22 09:00AM",
        "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-140002629.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-29-22 04:00PM",
        "title": "FDA Approval, Top Funds Lift Drugmaker In Ailing Market",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/141eb950-88e8-3c75-abad-bf18f8fe653c/fda-approval%2C-top-funds-lift.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-29-22 08:53AM",
        "title": "Pfizer (PFE) Pentavalent Meningitis Jab BLA Gets FDA Acceptance",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-pentavalent-meningitis-jab-135301654.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-29-22 05:13AM",
        "title": "3 High-Yield Dividend Stocks to Supercharge Your Passive Income Portfolio",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/acbd6575-6c71-3090-9ff3-3bcda211dc5c/3-high-yield-dividend-stocks.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-28-22 01:28PM",
        "title": "Our Predictions for the Top 7 Dividend Stocks for 2023",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/predictions-top-7-dividend-stocks-182817738.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-28-22 07:53AM",
        "title": "The Zacks Analyst Blog Highlights AbbVie, PepsiCo, Oracle, HSBC Holdings and The Progressive",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-abbvie-125312000.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-28-22 07:00AM",
        "title": "We Ran A Stock Scan For Earnings Growth And AbbVie (NYSE:ABBV) Passed With Ease",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/ran-stock-scan-earnings-growth-120048936.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-27-22 05:45PM",
        "title": "AbbVie (ABBV) Stock Moves -0.07%: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-moves-0-224510440.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-27-22 03:09PM",
        "title": "3 Dividend Kings Nicely Suited for Income Investors",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/3-dividend-kings-nicely-suited-200908310.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-27-22 03:04PM",
        "title": "Top Analyst Reports for AbbVie, PepsiCo & Oracle",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/top-analyst-reports-abbvie-pepsico-200408410.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-27-22 09:04AM",
        "title": "Buy shares of only the strongest companies to make money in 2023, including the kings of cash flow, says this five-star fund manager",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/6d2a8f3a-ff3e-34f0-b7f9-71749d915f56/buy-shares-of-only-the.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-24-22 09:20AM",
        "title": "2 Healthcare Stocks You Can Buy and Hold for the Next Decade",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/03f883be-30bb-32ce-8609-8d1b168e66d5/2-healthcare-stocks-you-can.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-24-22 08:21AM",
        "title": "AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvies-nyse-abbv-shareholders-receive-132153923.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-23-22 10:05AM",
        "title": "Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/roches-rhhby-lunsumio-gets-fda-150503255.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-23-22 09:16AM",
        "title": "If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c1c597d7-b339-362d-a3fd-9d933012ee56/if-you-invested-%2425%2C000-in.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-23-22 07:57AM",
        "title": "12 Best Performing Dividend Stocks in 2022",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-best-performing-dividend-stocks-125748956.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-23-22 06:01AM",
        "title": "Some Shareholders Feeling Restless Over AbbVie Inc.'s (NYSE:ABBV) P/E Ratio",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/shareholders-feeling-restless-over-abbvie-110116912.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-21-22 06:58PM",
        "title": "Dividend Champions List Ranked By Yield: Top 25",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/dividend-champions-list-ranked-yield-235848669.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-21-22 09:53AM",
        "title": "This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/709ebd2a-cc65-3d67-8d19-508c66f58e75/this-unstoppable-growth-stock.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-20-22 05:45PM",
        "title": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-224510568.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-20-22 05:47AM",
        "title": "2 Exceptional Dividend Growth Stocks to Buy Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/716dd1b1-a700-3b6c-83f6-1ee56d0cbf65/2-exceptional-dividend-growth.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-19-22 09:00AM",
        "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-140002237.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-19-22 07:26AM",
        "title": "AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/abbvie-abbv-vraylar-gets-fda-122612655.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-19-22 06:06AM",
        "title": "AbbVie's Antipsychotic Drug Scores FDA Approval As Adjunct Therapy For Depression Patients",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/abbvies-antipsychotic-drug-scores-fda-110601909.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-19-22 06:00AM",
        "title": "AbbVie Inc.'s (NYSE:ABBV) Intrinsic Value Is Potentially 90% Above Its Share Price",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-intrinsic-110044839.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-18-22 06:21PM",
        "title": "The 7 Hottest Biotech Stocks to Own in 2023 and Beyond",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-hottest-biotech-stocks-own-232117338.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-17-22 05:05AM",
        "title": "6 Stocks Warren Buffett Completely Exited in 2022",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/7f9209de-566c-3406-ae78-49e1b919cb0e/6-stocks-warren-buffett.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-16-22 08:20PM",
        "title": "Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/time-buy-eli-lilly-lly-012001697.html",
        "company": "ABBV"
    },
    {
        "releaseTime": "Dec-16-22 06:39PM",
        "title": "U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder",
        "publisher": " PR Newswire",
        "webUrl": "https://finance.yahoo.com/news/u-fda-approves-vraylar-cariprazine-233900038.html",
        "company": "ABBV"
    }
]